CENPB
Major centromere autoantigen B
Also known as: CENPB_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P07199
- Gene
- CENPB
- Ensembl
- ENSG00000125817
- Chromosome
- 20
- Canonical length
- 599 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene product is a highly conserved protein that facilitates centromere formation. It is a DNA-binding protein that is derived from transposases of the pogo DNA transposon family. It contains a helix-loop-helix DNA binding motif at the N-terminus, and a dimerization domain at the C-terminus. The DNA binding domain recognizes and binds a 17-bp sequence (CENP-B box) in the centromeric alpha satellite DNA. This protein is proposed to play an important role in the assembly of specific centromere structures in interphase nuclei and on mitotic chromosomes. It is also considered a major centromere autoantigen recognized by sera from patients with anti-centromere antibodies. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
599 residues, UniProt reviewed canonical sequence.
>P07199|CENPB
1 MGPKRRQLTF REKSRIIQEV EENPDLRKGE IARRFNIPPS TLSTILKNKR AILASERKYG
61 VASTCRKTNK LSPYDKLEGL LIAWFQQIRA AGLPVKGIIL KEKALRIAEE LGMDDFTASN
121 GWLDRFRRRH GVVSCSGVAR ARARNAAPRT PAAPASPAAV PSEGSGGSTT GWRAREEQPP
181 SVAEGYASQD VFSATETSLW YDFLPDQAAG LCGGDGRPRQ ATQRLSVLLC ANADGSEKLP
241 PLVAGKSAKP RAGQAGLPCD YTANSKGGVT TQALAKYLKA LDTRMAAESR RVLLLAGRLA
301 AQSLDTSGLR HVQLAFFPPG TVHPLERGVV QQVKGHYRQA MLLKAMAALE GQDPSGLQLG
361 LTEALHFVAA AWQAVEPSDI AACFREAGFG GGPNATITTS LKSEGEEEEE EEEEEEEEEG
421 EGEEEEEEGE EEEEEGGEGE ELGEEEEVEE EGDVDSDEEE EEDEESSSEG LEAEDWAQGV
481 VEAGGSFGAY GAQEEAQCPT LHFLEGGEDS DSDSEEEDDE EEDDEDEDDD DDEEDGDEVP
541 VPSFGEAMAY FAMVKRYLTS FPIDDRVQSH ILHLEHDLVH VTRKNHARQA GVRGLGHQSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CENPB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 170 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 170 nTPM
- midbrain: 142 nTPM
- hippocampal formation: 111 nTPM
- basal ganglia: 110 nTPM
- amygdala: 107 nTPM
- skeletal muscle: 89 nTPM
Single-cell type
- megakaryocytes: 43 nCPM
- foveolar cells: 42 nCPM
- smooth muscle cells: 42 nCPM
- pancreatic islet cells: 42 nCPM
- alveolar cells type 2: 40 nCPM
- pancreatic duct cells: 38 nCPM
Immune cell
- gdT-cell: 1.9 nTPM
- classical monocyte: 1.7 nTPM
- intermediate monocyte: 1.7 nTPM
- NK-cell: 1.7 nTPM
- plasmacytoid DC: 1.7 nTPM
- naive B-cell: 1.4 nTPM
Brain region
- white matter: 174 nTPM
- medulla oblongata: 155 nTPM
- spinal cord: 151 nTPM
- basal ganglia: 149 nTPM
- amygdala: 139 nTPM
- thalamus: 135 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CENPB.
Disease | ImmuneIEDB
Conditions an epitope on CENPB was assayed in.
- systemic scleroderma B cell
Disease | AutoantibodyPubMed
Conditions in which antibodies against CENPB are reported. Each links to that disease's full target list.
- Scleroderma, Systemic 23
- Liver Cirrhosis, Biliary 7
- Sjogren's Syndrome 7
- Arthritis, Rheumatoid 4
- Lupus Erythematosus, Systemic 4
- Breast Neoplasms 3
Showing 6 of 7 — disease pages carrying at least 10 antigens.
ReferencesPubMed · IEDB
Publications for CENPB from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
52 publications
- Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse.
2009 · J Immunol · RCR 4.1 · 159 citations - Disease-related autoantibody profile in patients with systemic sclerosis.
2017 · Autoimmunity · RCR 3.8 · 80 citations - Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku.
1992 · Am J Med · RCR 2.7 · 94 citations - Anti-centromere antibodies target centromere-kinetochore macrocomplex: a comprehensive autoantigen profiling.
2021 · Ann Rheum Dis · RCR 2.4 · 34 citations - Clinical and serological heterogeneity in patients with anticentromere antibodies.
2005 · J Rheumatol · RCR 2.2 · 75 citations
Show 20 more of 52 total
- Clinical correlates of CENP-A and CENP-B antibodies in a large cohort of patients with systemic sclerosis.
2012 · J Rheumatol · RCR 1.5 · 43 citations - High prevalence of antibodies to recombinant CENP-B in primary biliary cirrhosis: nuclear immunofluorescence patterns and ELISA reactivities.
1995 · J Gastroenterol Hepatol · RCR 1.2 · 38 citations - Distinct recognition of antibodies to centromere proteins in primary Sjogren's syndrome compared with limited scleroderma.
2006 · Ann Rheum Dis · RCR 1.2 · 44 citations - The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome.
1998 · Arthritis Rheum · RCR 1.2 · 37 citations - Surprising deficiency of CENP-B binding sites in African green monkey alpha-satellite DNA: implications for CENP-B function at centromeres.
1996 · Mol Cell Biol · RCR 1.1 · 64 citations - Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
2000 · J Rheumatol · RCR 1.1 · 40 citations - Antigen-driven selection of antibodies against SSA, SSB and the centromere 'complex', including a novel antigen, MIS12 complex, in human salivary glands.
2020 · Ann Rheum Dis · RCR 1 · 22 citations - Centromere protein B of African green monkey cells: gene structure, cellular expression, and centromeric localization.
1996 · Mol Cell Biol · RCR 0.8 · 46 citations - Increased Autoantibodies Against Ro/SS-A, CENP-B, and La/SS-B in Patients With Kidney Allograft Antibody-mediated Rejection.
2021 · Transplant Direct · RCR 0.8 · 11 citations - Associations of nailfold capillary abnormalities and immunological markers in early Raynaud's phenomenon.
2014 · Scand J Rheumatol · RCR 0.7 · 14 citations - Anticentromere-A and anticentromere-B antibodies show high concordance and similar clinical associations in patients with systemic sclerosis.
2010 · J Rheumatol · RCR 0.7 · 19 citations - A cross-sectional study of autoantibody profiles in the Waikato systemic sclerosis cohort, New Zealand.
2015 · Clin Rheumatol · RCR 0.7 · 17 citations - Nuclear autoantigen CENP-B transactivation of the epidermal growth factor receptor via chemokine receptor 3 in vascular smooth muscle cells.
2009 · Arthritis Rheum · RCR 0.6 · 21 citations - The role of anti-CENP-B and anti-SS-B antibodies in breast cancer.
2005 · Neoplasma · RCR 0.6 · 25 citations - Clinical and serological evaluation of a novel CENP-A peptide based ELISA.
2010 · Arthritis Res Ther · RCR 0.6 · 20 citations - Clinicolaboratory characteristics of patients with primary biliary cirrhosis associated with CREST symptoms.
2002 · Hepatol Res · RCR 0.6 · 20 citations - Reproducibility of fluid-phase measurements in PBS-treated sputum supernatant of healthy and stable COPD subjects.
2019 · Int J Chron Obstruct Pulmon Dis · RCR 0.5 · 13 citations - Clinical significance of elevated antinuclear antibody test in patients with Hodgkin's and Non-Hodgkin's lymphoma: a single center experience.
2008 · Minerva Med · RCR 0.5 · 19 citations - Anti-CENP-B antibodies are associated with prolonged survival in breast cancer.
2010 · Future Oncol · RCR 0.5 · 18 citations - Detection of IgE-autoantibodies to nuclear antigens in patients with systemic sclerosis and analysis of their clinical relevance.
2024 · Clin Exp Rheumatol · RCR 0.5 · 3 citations
Reference: B cellIEDB
3 publications
- Computational analysis of high-density peptide microarray data with application from systemic sclerosis to multiple sclerosis.
2012 · Autoimmun Rev · RCR 1 · 35 citations - A population of autoantibodies against a centromere-associated protein A major epitope motif cross-reacts with related cryptic epitopes on other nuclear autoantigens and on the Epstein-Barr nuclear antigen 1.
2001 · J Mol Med (Berl) · RCR 0.6 · 28 citations - Development of a CENP-A/CENP-B-specific immune response in a patient with systemic sclerosis.
2002 · Arthritis Rheum · RCR 0.5 · 22 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.18
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.73
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
- centromeric DNA binding
- chromatin binding
- DNA binding
- satellite DNA binding
- sequence-specific DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- DDE superfamily endonuclease domain
- HTH CenpB-type DNA-binding domain
- DNA binding HTH domain, Psq-type
- Homedomain-like superfamily
- Centromere and Transposable Element-Derived Protein
- DDE superfamily endonuclease
- Tc5 transposase DNA-binding domain
- CENP-B N-terminal DNA-binding domain
- Centromere protein CENP-B, C-terminal domain
- CENP-B, dimerisation domain superfamily
- Centromere protein B dimerisation domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CENPB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CENPB as an antibody target. Whether an autoantibody or antibody against CENPB could matter depends on whether native CENPB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CENPB is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Source-annotated serology context
The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.
- It is also considered a major centromere autoantigen recognized by sera from patients with anti-centromere antibodies.
Loading the interactive Seroatlas protein explorer...